期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性冠脉综合征患者的药学监护 被引量：1

Pharmaceutical Care for Patients with Acute Coronary Syndrome
原文传递
导出
摘要 目的:探讨临床药师对急性冠脉综合征(ACS)患者进行药学监护的内容和模式。方法:以4例ACS患者的药学监护为例,总结临床药师在ACS治疗过程中抗血小板药物、抗凝药物、抗心肌缺血药物、他汀类药物治疗的监护内容。结果:通过实施药学监护,临床药师及时发现并解决了患者在ACS治疗过程中的药品不良反应,患者症状均好转。结论:临床药师为ACS的治疗提供合理化的建议,从一定程度上保障了药物在临床使用过程中安全、合理和有效。 OBJECTIVE：To explore the content and mode of pharmaceutical care for patients with acute coronary syndrome（ACS）. METHODS：Taking pharmaceutical care for 4 ACS patients as example,the contents of pharmaceutical care provided by clinical pharmacists during ACS treatment were summarized involving antiplatelet drugs,anticoagulant,anti-myocardial ischemia drug,statins. RESULTS：Through pharmaceutical care,clinical pharmacists found and resolved ADR during ACS treatment timely.The symptoms of patients were improved. CONCLUSIONS：Clinical pharmacists provide reasonable suggestion for ACS treatment to guarantee safe,reasonable and effective use of drugs in the clinic.
作者 白颖 王家伟
机构地区 首都医科大学附属北京同仁医院药剂科
出处 《中国药房》 CAS 北大核心 2015年第26期3723-3725,共3页 China Pharmacy
关键词 急性冠脉综合征 临床药师 药学监护 Acute coronary syndrome Clinical pharmacist Pharmaceutical care
分类号 R969.4 [医药卫生—药理学] R971.2 [医药卫生—药品]
  • 相关文献

参考文献12

  • 1Steg PG,James SK,Atar D,et al.ESC guidelines for management of acute myocardial infarction in patients presenting with ST-segment elevation[J].Eur Heart J,2012,33(20):2 569.
  • 2Hamm CW,Bassand JP,Agewall S,et al.ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J].Eur Heart J,2011,32(23):2 999.
  • 3无,沈卫峰,胡大一.非ST段抬高急性冠状动脉综合征诊断和治疗指南[J].中华心血管病杂志,2012,40(5):353-367. 被引量：676
  • 4Bhatt DL,Cryer BL,Contant CF,et al.Clopidogrel with or without omeprazole in coronary artery disease[J].N Engl J Med,2010,11(20):1 909.
  • 5Kara?niewicz-?ada M,Danielak D,Burchardt P,et al.Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases[J].Clin Pharmcokinet,2014,53(2):155.
  • 6Maree AO,Fitzgerald DJ.Variable platelet response to aspirin and clopidogrel atherothrombotic disease[J].Circulation,2007,115(16):2 196.
  • 7Greinacher A,Farner B,Kroll H,et al.Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis.A retrospective analysis of408patients[J].Thromb Haemost,2005,94(1):132.
  • 8Miller CD,Roe MT,Mulgund J,et al.Impact of acute beta-blocker therapy for patients with non-ST-segment elevention myocardial infraction[J].Am J Med,2007,120(8):685.
  • 9无.1硝酸酯在心血管疾病中规范化应用的专家共识[J].中华心血管病杂志,2010,38(9):770-774. 被引量：52
  • 10<血管紧张素转换酶抑制剂在肾脏病中正确应用>专家协会组.血管紧张素转换酶抑制剂在肾脏病中正确应用的专家共识[J].中华肾脏病杂志,2006,22(1):57-58. 被引量：69

二级参考文献54

共引文献800

同被引文献17

  • 1万霞,刘建平.临床试验中的随机分组方法[J].中医杂志,2007,48(3):216-219. 被引量：87
  • 2Zhang XH, Lu ZL, Liu L.Coronary heart disease in China[J]. Heart,2008,94(9): 1126-1131. DOI: 10,1136/hrt,2007,132423,.
  • 3Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, et al.ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J].Eur Heart J,2012,33(20):2569-2619.
  • 4Hamm CW, Bassand JP, Agewall S, et aI.ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)[J].G Ital Cardiol (Rome),2012,13(3): 171-228.
  • 5Briffa TG, Hobbs MS, Tonkin A, et al.Population trends of recurrent coronary heart disease event rates remain high[J].Circ Cardiovasc Qual Outcomes,2011,4(1):107-113.
  • 6Weiner SD, Rabbani LE.Secondary prevention strategies for coronary heart disease[J].J Thromb Thrombolysis,2010,29(1):8-24. DOI: 10,1007/s 11239-009-0381-8.
  • 7European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al.ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)[J],Eur Heart J,2011,32( 14): 1769-1818. DOI: 10,1093/eurheartj/ehr 158.
  • 8Showkathali R, Natarajan A.Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review[J].Curr Cardiol Rev,2012,8(3):239-249.
  • 9Dagenais GR, Pugue J, Fox K, et al.Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventrieular systolic dysfunction or heart failure: a combined analysis of three trials[J]. Lancet,2006,368(9535):581-588.
  • 10Miller CD, Roe MT, Mulgund J, et al.Impaet of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction[J].Am J Med,2007,120(8):685-692.

引证文献1

二级引证文献4

中国药房
2015年 第26期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部